• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
    All News #Library
    Others

    Benitec Hosts BB-301 Forum at 2026 MDA Conference

    GLOBENEWSWIRE

    Benitec Biopharma Reports Q2 2025 Results, Gives Update

    GLOBENEWSWIRE

    Benitec Reports Durable Improvements In OPMD Subject At 180-Day Timepoint

    GLOBENEWSWIRE

    Benitec Biopharma Appoints Kishen Mehta To Board Of Directors

    GLOBENEWSWIRE

    Benitec Biopharma Releases Q3 2024 Results, Operational Update

    GLOBENEWSWIRE

    Benitec Biopharma Releases Second Quarter 2024 Financial Results

    GLOBENEWSWIRE

    Benitec Biopharma Releases First Quarter 2024 Financial Results

    GLOBENEWSWIRE

    Benitec Releases Full Year 2023 Financial Results & Provides Operational Update

    GLOBENEWSWIRE

    Benitec Biopharma Releases Second Quarter 2023 Financial Results

    GLOBENEWSWIRE

    Benitec Biopharma begins OPMD subject enrolment

    CLINICAL TRIALS ARENA

    Benitec Biopharma Enrolls First OPMD Subject into Clinical Development Program

    GLOBENEWSWIRE

    Benitec Biopharma Releases First Quarter 2023 Financial Results

    GLOBENEWSWIRE

    Benitec Biopharma Inc. Announces Closing of $18 Million UPO

    GLOBENEWSWIRE

    Benitec Biopharma Inc. Announces Pricing of $18 Million UPO

    GLOBENEWSWIRE

    Benitec Biopharma Releases Full Year 2022 Financial Results and Provides

    GLOBENEWSWIRE

    Benitec Biopharma Releases Q3 2022 Financial Results

    GLOBENEWSWIRE

    Benitec Biopharma Discloses Q2 2022 Financial Results

    PRNEWSWIRE

    Benitec Biopharma Provides Positive Updates on the BB-301 Pilot Dosing Study

    BIOSPACE

    Benitec Biopharma Provides Overview of the BB-301 Phase 1b/2a Trial

    BIOSPACE

    Benitec Biopharma Increases Previously Announced Bought Deal Offering

    PRNEWSWIRE

    Benitec Biopharma Announces Successful Results from the Interim Analysis

    PRNEWSWIRE

    Benitec Biopharma plunges 40% on equity offering

    SEEKINGALFA

    Aduro Biotech, American Renal Associates leads healthcare gainers; Benitec

    SEEKINGALFA

    Benitec reports FY results

    SEEKING ALPHA

    Benitec Begins Early Study of BB-301 Gene Therapy for OPMD

    MUSCULARDYSTROPHYNEWS

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.